Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NYMOX PHARMACEUTICAL CORPORATION

(NYMX)
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/21/2021 07/22/2021 07/23/2021 07/26/2021 07/27/2021 Date
1.35(c) 1.35(c) 1.34(c) 1.3(c) 1.31(c) Last
227 417 164 749 204 244 241 483 103 918 Volume
+1.50% 0.00% -0.74% -2.99% +0.77% Change
More quotes
Estimated financial data (e) (USD)
Sales 2019 0,12 M - -
Net income 2019 -13,2 M - -
Net cash position 2019 5,09 M - -
P/E ratio 2019 -11,5x
Yield 2019 -
Sales 2020 0,01 M - -
Net income 2020 -11,7 M - -
Net cash position 2020 3,19 M - -
P/E ratio 2020 -15,6x
Yield 2020 -
Capitalization 108 M 108 M -
EV / Sales 2019 1 283x
EV / Sales 2020 37 731x
Nbr of Employees -
Free-Float 55,0%
More Financials
Company
Nymox Pharmaceutical Corp is a Canada-based biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The Company operates through the research and development of products for the aging population segment. The Company markets NicAlert and TobacAlert tests that use urine... 
More about the company
All news about NYMOX PHARMACEUTICAL CORPORATION
06/25NYMOX PHARMACEUTICAL CORPORATION(NAS : NYMX) dropped from Russell 2000 Value Ind..
CI
06/25NYMOX PHARMACEUTICAL CORPORATION(NAS : NYMX) dropped from Russell Small Cap Comp..
CI
06/25NYMOX PHARMACEUTICAL CORPORATION(NAS : NYMX) dropped from Russell 3000 Value Ind..
CI
06/25NYMOX PHARMACEUTICAL CORPORATION(NAS : NYMX) dropped from Russell 3000 Index
CI
06/25NYMOX PHARMACEUTICAL CORPORATION(NAS : NYMX) dropped from Russell 3000E Growth I..
CI
06/25NYMOX PHARMACEUTICAL CORPORATION(NAS : NYMX) dropped from Russell 2500 Growth In..
CI
06/25NYMOX PHARMACEUTICAL CORPORATION(NAS : NYMX) dropped from Russell 3000E Index
CI
06/25NYMOX PHARMACEUTICAL CORPORATION(NAS : NYMX) dropped from Russell 2000 Index
CI
06/25NYMOX PHARMACEUTICAL CORPORATION(NAS : NYMX) dropped from Russell 3000 Growth In..
CI
06/25NYMOX PHARMACEUTICAL CORPORATION(NAS : NYMX) dropped from Russell Small Cap Comp..
CI
06/25NYMOX PHARMACEUTICAL CORPORATION(NAS : NYMX) dropped from Russell 2000 Dynamic I..
CI
06/25NYMOX PHARMACEUTICAL CORPORATION(NAS : NYMX) dropped from Russell 3000E Value In..
CI
06/25NYMOX PHARMACEUTICAL CORPORATION(NAS : NYMX) dropped from Russell Small Cap Comp..
CI
06/25NYMOX PHARMACEUTICAL CORPORATION(NAS : NYMX) dropped from Russell 2500 Value Ind..
CI
06/25NYMOX PHARMACEUTICAL CORPORATION(NAS : NYMX) dropped from Russell 2000 Growth In..
CI
More news
News in other languages on NYMOX PHARMACEUTICAL CORPORATION

- No features available -

More news
Chart NYMOX PHARMACEUTICAL CORPORATION
Duration : Period :
Nymox Pharmaceutical Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NYMOX PHARMACEUTICAL CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Paul Averback Chairman, President & Chief Executive Officer
Erik Danielsen Chief Financial Officer
Randall J. Lanham COO, Secretary, Director & General Counsel
David S. Morse Independent Director
James G. Robinson Independent Director
Sector and Competitors
1st jan.Capi. (M$)
NYMOX PHARMACEUTICAL CORPORATION-47.18%108
MODERNA, INC.214.44%131 902
LONZA GROUP AG20.01%55 520
IQVIA HOLDINGS INC.35.73%46 608
CELLTRION, INC.-26.60%31 131
SEAGEN INC.-17.54%26 209